UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000009595 |
|---|---|
| Receipt number | R000011253 |
| Scientific Title | Analysis of single nucleotide polymorphism in patients with age-related macular degeneration |
| Date of disclosure of the study information | 2012/12/21 |
| Last modified on | 2012/12/20 18:22:54 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Analysis of single nucleotide polymorphism in patients with age-related macular degeneration
Acronym
Genetic analysis of age-related macular degeneration
Scientific Title
Analysis of single nucleotide polymorphism in patients with age-related macular degeneration
Scientific Title:Acronym
Genetic analysis of age-related macular degeneration
Region
| Japan |
Condition
Condition
age-related macular degeneration
Cataract
Classification by specialty
| Ophthalmology | Adult |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
To analyze association between genetic polymorphisms and age-related macular degeneration
Basic objectives2
Others
Basic objectives -Others
To determine genetic association of single nucleotide polymorphisms in candidate genes with susceptibility to age-related macular degeneraiton
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Association of genetic polymorphism with age-related macular degeneration
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients diagnosed as age-related macular degeneration based on clinical characteristics. Normal health subjects without eye diseases (excluding cataract or ametropia).
Key exclusion criteria
Subjects who are deemed inappropriate for enrollment to this study by the investigator.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoshitsugu Inoue |
Organization
Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University
Division name
Division of Ophthalmology and Visual Science
Zip code
Address
36-1 Nishi-cho, Yonago Tottori 683-8504, Japan
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Dai Miyazaki |
Organization
Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University
Division name
Division of Ophthalmology and Visual Science
Zip code
Address
36-1 Nishi-cho, Yonago Tottori 683-8504, Japan
TEL
Homepage URL
Sponsor or person
Institute
Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University
Institute
Department
Personal name
Funding Source
Organization
Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 12 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2012 | Year | 10 | Month | 31 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 12 | Month | 21 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
case control study
Management information
Registered date
| 2012 | Year | 12 | Month | 20 | Day |
Last modified on
| 2012 | Year | 12 | Month | 20 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011253
